Skip to content
My WebMD Sign In, Sign Up

Cold, Flu, & Cough Health Center

Font Size
A
A
A

Swine Flu Vaccine at Least 6 Months Away

But CDC Says There Won't Be Enough Vaccine for Entire U.S. Population

Faster Swine Flu Vaccine? continued...

And according to media reports, Baxter already is in talks with the World Health Organization about making a swine flu version of its Celvapan vaccine. Baxter told Dow Jones Newswire it could make vaccine available 12 to 16 weeks after getting a seed strain of the virus.

And there are other technologies, too. For example, Novavax Inc., in Rockville, Md., says its virus-like particle technology could produce a swine flu vaccine in 10 to 12 weeks.

One reason officials may hesitate to order a flu vaccine made by methods that haven't yet met the FDA's safety standard is the U.S. experience during the 1976 swine flu scare.

That year, a deadly swine flu outbreak among military recruits in New Jersey led to crash development of a swine flu vaccine. Just as the vaccine was about to be deployed, vaccine makers asked the government to indemnify them against any possible harm the vaccine might cause.

That led people to suspect -- wrongly, as it turned out -- that the manufacturers suspected the vaccine was unsafe. And when serious side effects occurred in a small number of early vaccine recipients, the entire vaccine program came to a halt. Later analysis -- too late to save the CDC and the Ford administration major embarrassment -- showed these side effects weren't actually unusually frequent.

 WebMD senior writer Miranda Hitti contributed to this report.

1 | 2

Today on WebMD

neti pot
Slideshow
Chicken soup
Slideshow
 
Natural Cold Flu Remedies Slideshow
Slideshow
Syringes and graph illustration
TOOL
 
Natural Cold Flu Remedies Slideshow
Slideshow
blowing nose
Video
 
Allergy And Sinus Symptom Evaluator
Health Check
Boy holding ear
Article
 
woman receiving vaccine shot
Article
Bacterial or Viral Infection
Video
 
How To Calm Your Cough
Quiz
Sore Throat
Slideshow
 

WebMD Special Sections